Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	0	25
Total, all-cause mortality	Bulevirtide 2 mg/Day + PEG-IFN Alfa	1	50
Total, all-cause mortality	Bulevirtide 10 mg/Day + PEG-IFN Alfa	1	50
Total, all-cause mortality	Bulevirtide 10 mg/Day	0	50
Total, other adverse events	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	22	24
Total, other adverse events	Bulevirtide 2 mg/Day + PEG-IFN Alfa	49	50
Total, other adverse events	Bulevirtide 10 mg/Day + PEG-IFN Alfa	50	50
Total, other adverse events	Bulevirtide 10 mg/Day	37	50
Total, serious adverse events	Pegylated Interferon Alfa-2a (PEG-IFN Alfa)	3	24
Total, serious adverse events	Bulevirtide 2 mg/Day + PEG-IFN Alfa	3	50
Total, serious adverse events	Bulevirtide 10 mg/Day + PEG-IFN Alfa	8	50
Total, serious adverse events	Bulevirtide 10 mg/Day	2	50

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03852433/event-totals